Novartis India Ltd vs Onyx Biotec Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Jun 14, 2026

Key Highlights

The Latest Trading Price of Novartis India Ltd is ₹ 1303 as of 12 Jun 15:30 . The P/E Ratio of Novartis India Ltd changed from 65.2 on March 2021 to 19.2 on March 2025 . This represents a CAGR of -21.69% over 5 yearsThe P/E Ratio of Onyx Biotec Ltd changed from 21.3 on March 2025 to 21.3 on March 2025 . This represents a CAGR of 0.00% over 1 years The Market Cap of Novartis India Ltd changed from ₹ 1362 crore on March 2021 to ₹ 1938 crore on March 2025 . This represents a CAGR of 7.30% over 5 yearsThe Market Cap of Onyx Biotec Ltd changed from ₹ 105.17 crore on March 2025 to ₹ 105.17 crore on March 2025 . This represents a CAGR of 0.00% over 1 years The revenue of Novartis India Ltd for the Mar '26 is ₹ 100.56 crore as compare to the Dec '25 revenue of ₹ 94.65 crore. This represent the growth of 6.24% The revenue of Onyx Biotec Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Novartis India Ltd for the Mar '26 is ₹ 30.63 crore as compare to the Dec '25 ebitda of ₹ 31.11 crore. This represent the decline of -1.54% The ebitda of Onyx Biotec Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Novartis India Ltd changed from ₹ 25.74 crore to ₹ 25.25 crore over 8 quarters. This represents a CAGR of -0.96% The net profit of Onyx Biotec Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% The Dividend Payout of Novartis India Ltd changed from 118.09 % on March 2021 to 61.15 % on March 2025 . This represents a CAGR of -12.33% over 5 yearsThe Dividend Payout of Onyx Biotec Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Novartis India Ltd

Novartis India Limited (NIL) is a subsidiary of Swiss giant Novartis, the world's second largest pharmaceutical company was incorporated on 13 December 1947.
The Company is engaged in manufacturing and marketing of drugs, pharmaceutical products and formulations for consumer healthcare and animal healthcare; it operates into four segments such as Pharmaceuticals, Generics, Over the Trade Counter and Animal Health. The origin of Novartis is linked to the origin of three distinct companies namely Geigy, Ciba, and Sandoz.
The history of Geigy goes back to the middle of the 18th century, Ciba was founded around 1860, and Sandoz was set-up in 1886.
In 1970 Ciba and Geigy merged to form Ciba-Geigy Ltd. Sandoz and Ciba-Geigy Ltd continued as separate entities for the next 25 years.
In 1996, in one of the largest corporate mergers in history Sandoz and Ciba-Geigy Ltd.

About Onyx Biotec Ltd

Onyx Biotec Limited was incorporated as Onyx Biotec Private Limited', pursuant to a Certificate of Incorporation dated May 13, 2005 issued by the Registrar of Companies, Punjab, H.P. & Chandigarh.
Further, Company converted into a Public Limited and the name was changed to Onyx Biotec Limited' and a fresh Certificate of Incorporation dated July 23, 2024 was issued by the Registrar of Companies, Central Processing Centre. Onyx started its operation in pharmaceutical industry with sterile water for injections with capacity of 2 lacs units per day in year 2010.
Since then, Onyx is engaged in Manufacturing of Pharmaceutical Products such as sterile water ampoule, dry injection, dry syrup etc. to major corporations, which includes the top pharma companies. Presently, the Company manufactures Sterile Water for Injections, and acts as a pharmaceutical contract manufacturer offering a comprehensive range of Dry Powder Injections and Dry Syrup for India and overseas.

FAQs for the comparison of Novartis India Ltd and Onyx Biotec Ltd

Which company has a larger market capitalization, Novartis India Ltd or Onyx Biotec Ltd?

Market cap of Novartis India Ltd is 3,219 Cr while Market cap of Onyx Biotec Ltd is 71 Cr

What are the key factors driving the stock performance of Novartis India Ltd and Onyx Biotec Ltd?

The stock performance of Novartis India Ltd and Onyx Biotec Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Novartis India Ltd and Onyx Biotec Ltd?

As of June 14, 2026, the Novartis India Ltd stock price is INR ₹1303.85. On the other hand, Onyx Biotec Ltd stock price is INR ₹39.2.

How do dividend payouts of Novartis India Ltd and Onyx Biotec Ltd compare?

To compare the dividend payouts of Novartis India Ltd and Onyx Biotec Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.